Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image

New

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Report
180 Pages
March 2025
Region: Global
TechSci Research
ID: 5908381

Global Swine Vaccines Market was valued at USD 1.32 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.85% through 2030. The global swine vaccines market is a vital segment of the animal health industry that focuses on preventing and managing diseases in swine populations. Swine vaccines play a crucial role in ensuring the health and productivity of pigs in the swine farming sector, which is a significant component of the global meat industry. For instance, according to the World Population Review’s Pork Consumption Data 2024, global pork consumption stands at 112.6 kilotons and is expected to rise to 129 kilotons by 2031. This increasing demand, especially in Asia-Pacific, Europe, and North America, underscores the need for healthy and productive swine herds. To sustain supply and quality, pig producers are prioritizing disease prevention through effective vaccination, driving market growth as they adopt advanced biosecurity measures to enhance herd health and efficiency.

Key Market Drivers

Rising Demand for Pork

The world's population is steadily increasing, and with it, the demand for protein-rich foods like pork is on the rise. As more people move to urban areas, their dietary preferences tend to shift towards meat-based diets. This urbanization trend amplifies the demand for pork products, leading to larger swine farming operations. To meet this burgeoning demand, farmers rely on swine vaccines to ensure the health and productivity of their herds.

Emerging markets in regions such as Asia, Latin America, and Africa are witnessing a rapid expansion of their middle-class populations. As incomes rise, so does the consumption of animal protein, including pork. This socio-economic shift is a major driver of increased demand for pork and, consequently, for swine vaccines. To meet the quality and safety standards demanded by this growing middle-class consumer base, swine farmers invest in disease prevention through vaccination.

Food security is a pressing concern in a world that needs to feed a growing population sustainably. Pork is an efficient source of protein, as pigs can convert feed into meat relatively quickly compared to other livestock. Ensuring the health and well-being of swine herds through vaccination is a key component of sustainable swine farming. Healthy pigs mean higher yields, reduced waste, and a more sustainable food supply chain.

Key Market Challenges

Emerging Diseases and Pathogens

The swine industry faces an ongoing threat from emerging diseases and evolving strains of existing pathogens. New diseases, such as African swine fever (ASF) and novel strains of influenza, can have devastating consequences for swine herds. Developing effective vaccines to combat these emerging threats is a constant challenge for vaccine manufacturers.

Key Market Trends

Precision Vaccination

One of the emerging trends in the swine vaccines market is precision vaccination. Traditional vaccines provide broad protection against a range of pathogens, but advances in vaccine technology now allow for more precise targeting of specific diseases. This trend helps swine farmers address unique disease challenges and reduce the potential for adverse reactions.

Key Market Players

Merck & Co Inc
Zoetis Inc
Boehringer Ingelheim GmbH
Elanco Animal Health Inc
Indian Immunologicals Ltd
Biogénesis Bagó SA
Phibro Animal Health Corp
Laboratorios HIPRA SA
Virbac SA

Report Scope:

In this report, the Global Swine Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Vaccines Market, By Product:

Attenuated Live Vaccines
DNA Vaccines
Inactivated Vaccines
Recombinant Vaccines
Subunit Vaccines

Swine Vaccines Market, By Type:

Actinobacillus Pleuropneumoniae
Classical Swine Fever
Foot & Mouth Disease
PEDV
Porcine Circovirus Type 2
Porcine Parvovirus
PRRS
Pseudorabies
Swine Influenza

Swine Vaccines Market, By Target Disease:

Arthritis
Bordetella Rhinitis
Diarrhea
Foot & Mouth Disease
Porcine Circovirus Associated Disease
Porcine Reproductive & Respiratory Syndrome
Pseudorabies
Swine Influenza

Swine Vaccines Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Vaccines Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Vaccines Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
5.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
5.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Type
5.3.3. By Target Disease
5.3.4. By Region

6. North America Swine Vaccines Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
6.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
6.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Swine Vaccines Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Target Disease
6.3.2. Canada Swine Vaccines Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Target Disease
6.3.3. Mexico Swine Vaccines Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Target Disease

7. Europe Swine Vaccines Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
7.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
7.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Swine Vaccines Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Target Disease
7.3.2. United Kingdom Swine Vaccines Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Target Disease
7.3.3. France Swine Vaccines Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Target Disease
7.3.4. Italy Swine Vaccines Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Target Disease
7.3.5. Spain Swine Vaccines Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Target Disease

8. Asia-Pacific Swine Vaccines Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
8.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
8.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Swine Vaccines Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Target Disease
8.3.2. Japan Swine Vaccines Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Target Disease
8.3.3. India Swine Vaccines Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Target Disease
8.3.4. Australia Swine Vaccines Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Target Disease
8.3.5. South Korea Swine Vaccines Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Target Disease

9. South America Swine Vaccines Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
9.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
9.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Swine Vaccines Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Target Disease
9.3.2. Argentina Swine Vaccines Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Target Disease
9.3.3. Colombia Swine Vaccines Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Target Disease

10. Middle East and Africa Swine Vaccines Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
10.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
10.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Swine Vaccines Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Target Disease
10.3.2. Saudi Arabia Swine Vaccines Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Target Disease
10.3.3. UAE Swine Vaccines Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Target Disease
10.3.4. Kuwait Swine Vaccines Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Type
10.3.4.2.3. By Target Disease

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter’s Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Merck & Co Inc
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Zoetis Inc
14.3. Boehringer Ingelheim GmbH
14.4. Elanco Animal Health Inc
14.5. Indian Immunologicals Ltd
14.6. Biogénesis Bagó SA
14.7. Phibro Animal Health Corp
14.8. Laboratorios HIPRA SA
14.9. Virbac SA

15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

Merck & Co Inc
Zoetis Inc
Boehringer Ingelheim GmbH
Elanco Animal Health Inc
Indian Immunologicals Ltd
Biogénesis Bagó SA
Phibro Animal Health Corp
Laboratorios HIPRA SA
Virbac SA

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.32 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.74 Billion
Compound Annual Growth Rate	4.8%
Regions Covered	Global
No. of Companies Mentioned	9

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4038EUR$4,500USD£3,475GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4935EUR$5,500USD£4,247GBP